JPMorgan Securities Plc UDG Healthcare Plc 38.5a (6278I)

TIDMUDG

RNS Number : 6278I

JPMorgan Securities Plc

13 August 2021

Ap24

   FORM   38.5(a) 
   IRISH  TAKEOVER   PANEL 
   DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH  TAKEOVER   PANEL ACT,  1997,  TAKEOVER  RULES, 2013 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A

CLIENT-SERVING   CAPACITY 
   1.       KEY   INFORMATION 
 
Name of exempt principal    J.P. Morgan Securities 
 trader                      Plc 
Company dealt in            UDG Healthcare Plc 
                            ======================= 
Class of relevant security  EUR0.05 ordinary shares 
 to which the dealings 
 being disclosed relate 
 (Note 1) 
                            ======================= 
Date of dealing             12 August 2021 
                            ======================= 
 
   2.        DEALINGS  (Note   2) 
   (a)      Purchases and sales 
 
     Total number             Highest price paid     Lowest price 
      of relevant                  (Note 3)              paid 
  securities acquired                                  (Note 3) 
       89,514                 10.8000 GBP           10.7800 GBP 
                       =========================  =============== 
 
 
  Total number          Highest price received     Lowest price 
  of securities                (Note 3)              received 
    disposed                                         (Note 3) 
    71,249                10.7900 GBP             10.7784 GBP 
                 =============================  =============== 
 
   (b)      Derivatives transactions (other than options transactions) 
 
  Product     Nature of transaction   Number of relevant    Price per 
    name,            (Note 4)             securities           unit 
  e.g. CFD                                 (Note 5)          (Note 3) 
Equity Swap      Decrease Long             13,263         10.7801 GBP 
                                              1            10.7900 GBP 
                                            5,905          10.7901 GBP 
                                             411           10.7902 GBP 
 
                 Decrease Short             2,600          10.7899 GBP 
 
                  Increase Long             10,500         10.7784 GBP 
                                            2,191          10.7786 GBP 
                                            1,220          10.7795 GBP 
                                              1            10.7800 GBP 
                                              6            10.7825 GBP 
                                            1,316          10.7828 GBP 
                                            1,827          10.7829 GBP 
                                            1,000          10.7898 GBP 
 
                 Increase Short             6,362          10.7809 GBP 
                                            13,000         10.7859 GBP 
             ======================  ===================  ============ 
 

Ap25

   (c)      Options transactions in respect of existing relevant securities 
   (i)       Writing,   selling, purchasing or varying 
 
  Product       Writing,      Number of      Exercise        Type,       Expiry          Option 
    name,       selling,      securities       price     e.g. American,   date     money paid/received 
  e.g. call    purchasing,     to which                     European                    per unit 
   option        varying      the option                      etc.                      (Note 3) 
                  etc.       relates (Note 
                                  5) 
 
 
   (ii)      Exercising 
 
Product name,             Number of securities      Exercise price 
 e.g. call option                                    per unit (Note 
                                                     3) 
 
 
   3.      OTHER  INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other

person   relating   to   the 

voting rights of any relevant securities under any option referred to on this form

or   relating   to   the   voting   rights  or future acquisition 

or disposal of any relevant securities to which any derivative referred to on this form is

referenced.   If   none,   this   should   be   stated. 
 
Date of disclosure           13 August 2021 
Contact name                 Alwyn Basch 
                             ========================= 
Telephone number             020 7742 7407 
                             ========================= 
Name of offeree/offeror      UDG Healthcare Plc 
 with which connected 
                             ========================= 
Nature of connection (Note   Financial adviser to CD&R 
 6)                           Fund XI 
                             ========================= 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEPJMMTMTJBBAB

(END) Dow Jones Newswires

August 13, 2021 06:36 ET (10:36 GMT)